GeoVax Labs (GOVX) EBITDA (2016 - 2025)
Historic EBITDA for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to -$6.4 million.
- GeoVax Labs' EBITDA fell 885.87% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.5 million, marking a year-over-year decrease of 427.89%. This contributed to the annual value of -$25.1 million for FY2024, which is 597.79% up from last year.
- Latest data reveals that GeoVax Labs reported EBITDA of -$6.4 million as of Q3 2025, which was down 885.87% from -$5.4 million recorded in Q2 2025.
- In the past 5 years, GeoVax Labs' EBITDA ranged from a high of -$1.5 million in Q2 2021 and a low of -$13.7 million during Q4 2021
- Its 5-year average for EBITDA is -$5.4 million, with a median of -$5.4 million in 2025.
- In the last 5 years, GeoVax Labs' EBITDA crashed by 92788.53% in 2021 and then surged by 6080.03% in 2022.
- Quarter analysis of 5 years shows GeoVax Labs' EBITDA stood at -$13.7 million in 2021, then soared by 60.8% to -$5.4 million in 2022, then crashed by 42.81% to -$7.7 million in 2023, then fell by 8.46% to -$8.3 million in 2024, then rose by 23.62% to -$6.4 million in 2025.
- Its last three reported values are -$6.4 million in Q3 2025, -$5.4 million for Q2 2025, and -$5.4 million during Q1 2025.